Att försöka lära sig översätta från mänskliga översättningsexempel.
Från professionella översättare, företag, webbsidor och fritt tillgängliga översättningsdatabaser.
suitable tests to distinguish between birds vaccinated and those infected with the field strain of avian influenza;
testijiet xierqa biex issir distinzjoni bejn għasafar imlaqqmin u dawk infettati bil-varjant preżenti (field strain) ta’ l-influwenza tat-tjur;
distinguishing between field strains and the vaccine strain of m. synoviae can be performed by hammond classification or high resolution melt (hrm) testing by a laboratory.
distinzjoni bejn ir-razza attwali u r-razza tal-vaċċin ta’ m.synoviae tista’ ssir permezz ta’ ittestjar bil-klassifikazzjoni ta’ hammond jew high resolution melt (hrm) f’laboratorju.
the level of efficacy attained may vary depending on the degree of antigenic homology between the vaccine strain and circulating field strains.
il-livell ta’ effikaċja milħuq jista’ jvarja u jiddependi minn kemm jixxiebhu l-istrejn tal-vaċċin u l- istrejns jiċċirkulaw fil-beraħ.
appropriate panels of monoclonal antibodies are then reacted and the binding of monoclonal antibodies to field strains is compared to the binding of monoclonal antibodies to the parental strains.
panewwi xierqa ta’ monoclonal antibodies huma imbagħad jitħaltu ma’ xulxin u l-għaqda ta’ monoclonal antibodies ma’ field strains huwa mqabbel mall-għaqda ta’ monoclonal antibodies ma’ strains parentali.
eleven genetic markers (nucleotides) in the vp1 gene allow differentiation of the parvoduk vaccine strain from the field strains of duck and goose parvovirus, as shown below:
Ħdax-il marker ġenetiku (nukleotidi) fil-ġene vpi jippermettu differenzjar tal-istrejn tal-vaċċin tal- parvoduk mill-istrejnijiet li jinstabu barra tal-parvovirus tal-papri u tal-wiżż, kif jigi muri hawn taħt:
this strain has been chosen because it protects birds against virulent h5n1 field strains (cross-protection), while allowing differentiation of vaccinated from infected birds.
din ir-razza ġiet magħżula minħabba li tipproteġi l-għasafar kontra d-damma tar-razza h5 virulenti (protezzjoni inkroċjata), filwaqt li twassal minn għasafar infettati għal dawk vaċċinati.
testing, by means of cross-immunity assays in live cattle, the efficacy of existing vaccines against important new field strains of foot-and-mouth disease virus and communicating the results of such assays without delay to the commission and the member states;
(ċ) bl-ittestjar, permezz ta’ assaġġi ta’ cross-immunity f’frat ħaj, l-effikaċja ta’ tilqim eżistenti kontra razez ġodda importanti tal-virus tal-marda ta’ l-islien u d-dwiefer u l-komunikazzjoni tar-riżultati ta’ dawn l-assaġġi mingħajr dewmien lill-kummissjoni u lill-istati membri;